Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Phase 3 Study of 18F-florbetaben Positron Emission Tomography/Computed Tomography (PET-CT) to Non-invasively Diagnose Cardiac AL Amyloidosis

NCT06048601 is registered in ClinicalTrials.gov with Fondazione Toscana Gabriele Monasterio as lead sponsor.

NCT NCT06048601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06048601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Phase 3 Study of 18F-florbetaben Positron Emission Tomography/Computed Tomography (PET-CT) to Non-invasively Diagnose Cardiac AL Amyloidosis
Lead sponsor
Fondazione Toscana Gabriele Monasterio
Phase
Not applicable
Overall status
Unknown status
Start date
January 26, 2023
Completion date
January 31, 2025
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloid, amyloid cardiomyopathy